Health research ethics committees (HRECs) protect the interests of patients who participate in medical research. Citing the widespread disapproval of these committees at the moment, Steve Leeder calls for their roles to be clarified. He rejects the calls by drug companies for these committees to be centralized and makes four recommendations to improve them